Combination targeted treatment produces lasting remissions in people with resistant aggressive B-cell lymphoma
Researchers have developed a non-chemotherapy treatment regimen that is achieving full remissions for some people with aggressive B-cell lymphoma that has come back or is no longer responding to standard treatments. The five-drug combination targets mu…